Evidence map›Paper›PMID 39713201›Full record

ReviewExploration (Beijing, China)2024

Metal-based smart nanosystems in cancer immunotherapy.

Ying Luo, Xiaojing He, Qianying Du, Lian Xu, Jie Xu, Junrui Wang, Wenli Zhang, Yixin Zhong, Dajing Guo, Yun Liu and 1 more

Abstract readReview
In one paragraph

Review in Exploration (Beijing, China), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Early Transition Metal-Based Antitumor Complexes.Chemistry, an Asian journal · 2026
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Ferrum@albumin assembled nanoclusters inhibit NF-Acta pharmaceutica Sinica. B · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ying LuoDepartment of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China.
Xiaojing HeDepartment of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China.
Qianying DuDepartment of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China.
Lian XuDepartment of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China.
Jie XuDepartment of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China.
Junrui WangDepartment of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China.
Wenli ZhangDepartment of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China.
Yixin ZhongDepartment of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China.
Dajing GuoDepartment of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China.
Yun LiuDepartment of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing People's Republic of China.
Xiaoyuan ChenDepartment of Diagnostic Radiology Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore.ORCID https://orcid.org/0000-0002-9622-0870

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metals are an emerging topic in cancer immunotherapy that have shown great potential in modulating cancer immunity cycle and promoting antitumor immunity by activating the intrinsic immunostimulatory mechanisms which have been identified in recent years. The main challenge of metal-assisted immunotherapy lies in the fact that the free metals as ion forms are easily cleared during circulation, and even cause systemic metal toxicity due to the off-target effects. With the rapid development of nanomedicine, metal-based smart nanosystems (MSNs) with unique controllable structure become one of the most promising delivery carriers to solve the issue, owing to their various endogenous/external stimuli-responsiveness to release free metal ions for metalloimmunotherapy. In this review, the state-of-the-art research progress in metal-related immunotherapy is comprehensively summarized. First, the mainstream mechanisms of MSNs-assisted immunotherapy will be delineated. The immunological effects of certain metals and categorization of MSNs with different characters and compositions are then provided, followed by the representative exemplar applications of MSNs in cancer treatment, and synergistic combination immunotherapy. Finally, we conclude this review with a summary of the remaining challenges associated with MSNs and provide the authors' perspective on their further advances.

Indexed as

cancer immunity cycleimmunotherapymetal ionssmart nanosystemtumor microenvironment

Identifiers

PMID39713201
PMCPMC11655314

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.